{"id":8543,"date":"2022-05-31T03:19:32","date_gmt":"2022-05-30T19:19:32","guid":{"rendered":"https:\/\/amdl.com.hk\/?p=8543"},"modified":"2024-03-01T16:09:50","modified_gmt":"2024-03-01T08:09:50","slug":"pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology","status":"publish","type":"post","link":"https:\/\/amdl.com.hk\/zh\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/","title":{"rendered":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"8543\" class=\"elementor elementor-8543\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-aea05bc e-flex e-con-boxed e-con e-parent\" data-id=\"aea05bc\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;gradient&quot;,&quot;motion_fx_motion_fx_scrolling&quot;:&quot;yes&quot;,&quot;animation&quot;:&quot;none&quot;,&quot;_ha_eqh_enable&quot;:false,&quot;motion_fx_devices&quot;:[&quot;desktop&quot;,&quot;tablet&quot;,&quot;mobile&quot;]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-7e3d5c3 e-flex e-con-boxed e-con e-parent\" data-id=\"7e3d5c3\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3d20f3d elementor-widget elementor-widget-heading\" data-id=\"3d20f3d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3ca870f elementor-widget elementor-widget-text-editor\" data-id=\"3ca870f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>May 31, 2022<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a12d4b2 e-flex e-con-boxed e-con e-parent\" data-id=\"a12d4b2\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c3ddcd3 elementor-widget elementor-widget-text-editor\" data-id=\"c3ddcd3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Home \u00a0&gt; \u00a0Resources \u00a0&gt; \u00a0<a href=\"https:\/\/amdl.com.hk\/press-release\/\">Press Release<\/a>\u00a0 &gt; Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4b79e25 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"4b79e25\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e8b96cc e-flex e-con-boxed e-con e-parent\" data-id=\"e8b96cc\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c386d1d elementor-widget elementor-widget-text-editor\" data-id=\"c386d1d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tStudy entitled \u201cReducing Pre-analytical Sample QC Failure Rates for Cancer Molecular Genetic Assays with SLIMamp\u00ae Technology\u201d published in conjunction with the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting\n\nNATICK, Mass. \u2013 May 31, 2022 \u2013 (BUSINESS WIRE) \u2013 Pillar Biosciences, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment initiation and overall testing costs, today announced that its abstract, \u201cReducing Pre-analytical Sample QC Failure Rates for Cancer Molecular Genetic Assays with SLIMamp\u00ae Technology\u201d, has been published online in the Journal of Clinical Oncology, in conjunction with the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting. The company will also be showcasing its highly accurate and sensitive NGS genetic testing technology at booth #17157 June 4 through June 6, 2022.\n\n\u201cThere is a critical need for NGS tests that can accurately and rapidly identify somatic variants in cancer patients. Current NGS tests can have high failure rates which delay the return of actionable results to physicians, significantly impacting time to diagnosis and critical treatment decisions,\u201d said Randy Pritchard, CEO of Pillar Biosciences. \u201cThe findings from our study underscore the accuracy and reliability of our SLIMamp\u00ae technology and demonstrate its ability to generate highly accurate results from lower quality samples that have failed other NGS tests. We are pleased that this study has been published online and look forward to demonstrating the capabilities of our NGS genetic testing solutions at ASCO.\u201d\n\nIn the study, 48 tumor samples failing one or more pre-analytical quality control (QC) sample parameters for whole exome sequencing (WES) from an accredited diagnostic genomics laboratory were sequenced using Pillar Bioscience\u2019s oncoRevealTM Solid Tumor Panel. Results demonstrated that the panel achieved high sequencing coverage (>3,000X) for all 48 samples and was able to generate clinical reports for 45 samples (94%). 38 of these reports (79%) contained clinically actionable or significant variants that would not have otherwise been identified with currently available panels. The study showed that oncoReveal\u2122 Solid Tumor Panel with Pillar Biosciences\u2019 proprietary SLIMamp\u00ae technology, was able to generate reliable, interpretable results for almost all of the samples that had failed pre-analytical QC for WES.\u00a0\n\nAt booth #17157, Pillar Biosciences will also be featuring the company\u2019s extensive portfolio of NGS genetic testing solutions, including the oncoReveal\u2122 Dx Lung and Colon Cancer Assay, PillarHS Multi-Cancer Panel, Essential MPN Panel, Multi-Cancer with CNV and RNA Fusion Panel, and Myeloid Panel.\n\nAbout Pillar Biosciences\n\nPillar Biosciences is the leader in Decision Medicine\u2122, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar\u2019s NGS testing solutions, including the FDA-approved oncoReveal\u2122 Dx Lung and Colon Cancer Assay, are powered by the Company\u2019s proprietary SLIMamp\u00ae and PiVAT\u00ae technologies, and decentralize the testing process, reducing diagnostic costs and improving access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The Company has more than 20 NGS testing products available in IVD or RUO formats, and several others in various stages of development, including a pan-cancer oncoReveal\u2122 CDx assay, and two liquid biopsy offerings. Pillar\u2019s patented technologies have been shown to provide accurate and actionable data in as little as 48 hours, which allows physicians to select appropriate therapies and monitor the patient\u2019s response. Pillar Biosciences has operations in Natick, MA and Shanghai, China. For more information, visit\u00a0www.pillar-biosciences.com.\u00a0\u00a0\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology May 31, 2022 Home \u00a0&gt; \u00a0Resources \u00a0&gt; \u00a0Press Release\u00a0 &gt; Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology Study entitled \u201cReducing Pre-analytical Sample QC Failure Rates for Cancer Molecular Genetic Assays with SLIMamp\u00ae Technology\u201d published in conjunction with the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting NATICK, Mass. \u2013 May 31, 2022 \u2013 (BUSINESS WIRE) \u2013 Pillar Biosciences, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment initiation [&hellip;]<\/p>\n","protected":false},"author":214404991,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":null,"ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"disabled","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[96987498,96987711],"tags":[96987715,96987713],"class_list":["post-8543","post","type-post","status-publish","format-standard","hentry","category-uncategorized","category-pillar-biosciences","tag-96987715","tag-pillar-biosciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong<\/title>\n<meta name=\"description\" content=\"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products &amp; services for oncologist and clients in Hong Kong, China &amp; Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amdl.com.hk\/zh\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"zh_HK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\" \/>\n<meta property=\"og:description\" content=\"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products &amp; services for oncologist and clients in Hong Kong, China &amp; Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amdl.com.hk\/zh\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-30T19:19:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-01T08:09:50+00:00\" \/>\n<meta name=\"author\" content=\"amdlint\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"amdlint\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u8a08\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/\"},\"author\":{\"name\":\"amdlint\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#\\\/schema\\\/person\\\/7dcadaf75d73ac6327b3700429c56113\"},\"headline\":\"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology\",\"datePublished\":\"2022-05-30T19:19:32+00:00\",\"dateModified\":\"2024-03-01T08:09:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/\"},\"wordCount\":611,\"publisher\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#organization\"},\"keywords\":[\"2022\",\"Pillar Biosciences\"],\"articleSection\":[\"2022\",\"Pillar Biosciences\"],\"inLanguage\":\"zh-HK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/\",\"url\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/\",\"name\":\"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#website\"},\"datePublished\":\"2022-05-30T19:19:32+00:00\",\"dateModified\":\"2024-03-01T08:09:50+00:00\",\"description\":\"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products & services for oncologist and clients in Hong Kong, China & Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/#breadcrumb\"},\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/amdl.com.hk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#website\",\"url\":\"https:\\\/\\\/amdl.com.hk\\\/\",\"name\":\"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\",\"description\":\"We bring world-class diagnostic technologies to break\\u000bthe genetic code of cancer tumors for saving lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amdl.com.hk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-HK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#organization\",\"name\":\"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\",\"url\":\"https:\\\/\\\/amdl.com.hk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/amdl.com.hk\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/AMDL-Logo_RGB_For-Online-use-01.png?fit=2584%2C709&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/amdl.com.hk\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/AMDL-Logo_RGB_For-Online-use-01.png?fit=2584%2C709&ssl=1\",\"width\":2584,\"height\":709,\"caption\":\"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong\"},\"image\":{\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/hk.linkedin.com\\\/company\\\/asia-molecular-diagnostics-laboratory\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amdl.com.hk\\\/#\\\/schema\\\/person\\\/7dcadaf75d73ac6327b3700429c56113\",\"name\":\"amdlint\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g\",\"caption\":\"amdlint\"},\"url\":\"https:\\\/\\\/amdl.com.hk\\\/zh\\\/author\\\/amdlint\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","description":"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products & services for oncologist and clients in Hong Kong, China & Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amdl.com.hk\/zh\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/","og_locale":"zh_HK","og_type":"article","og_title":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","og_description":"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products & services for oncologist and clients in Hong Kong, China & Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.","og_url":"https:\/\/amdl.com.hk\/zh\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/","og_site_name":"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","article_published_time":"2022-05-30T19:19:32+00:00","article_modified_time":"2024-03-01T08:09:50+00:00","author":"amdlint","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"amdlint","\u9810\u8a08\u95b1\u8b80\u6642\u9593":"3 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/#article","isPartOf":{"@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/"},"author":{"name":"amdlint","@id":"https:\/\/amdl.com.hk\/#\/schema\/person\/7dcadaf75d73ac6327b3700429c56113"},"headline":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology","datePublished":"2022-05-30T19:19:32+00:00","dateModified":"2024-03-01T08:09:50+00:00","mainEntityOfPage":{"@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/"},"wordCount":611,"publisher":{"@id":"https:\/\/amdl.com.hk\/#organization"},"keywords":["2022","Pillar Biosciences"],"articleSection":["2022","Pillar Biosciences"],"inLanguage":"zh-HK"},{"@type":"WebPage","@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/","url":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/","name":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology | Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","isPartOf":{"@id":"https:\/\/amdl.com.hk\/#website"},"datePublished":"2022-05-30T19:19:32+00:00","dateModified":"2024-03-01T08:09:50+00:00","description":"Asia Molecular Diagnostic Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 is a molecular diagnostic laboratory in Hong Kong. AMDL is a subsidiary of China Biotech Services Holdings Limited \u4e2d\u570b\u751f\u7269\u79d1\u6280\u670d\u52d9\u63a7\u80a1\u6709\u9650\u516c\u53f8. We have An NGS-level molecular laboratory at HKSTP. We are sole distributor of Pillar Biosciences products in Asia and providing world-leading NGS-based clinical testing products & services for oncologist and clients in Hong Kong, China & Asia. Our company offers cancer diagnostic testing services to clients in Asia, aiming to provide accurate and robust cancer diagnostic report to clinicians for appropriate therapies.","breadcrumb":{"@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/#breadcrumb"},"inLanguage":"zh-HK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amdl.com.hk\/pillar-biosciences-announces-online-publication-of-data-in-the-journal-of-clinical-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/amdl.com.hk\/"},{"@type":"ListItem","position":2,"name":"Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology"}]},{"@type":"WebSite","@id":"https:\/\/amdl.com.hk\/#website","url":"https:\/\/amdl.com.hk\/","name":"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","description":"We bring world-class diagnostic technologies to break\u000bthe genetic code of cancer tumors for saving lives.","publisher":{"@id":"https:\/\/amdl.com.hk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amdl.com.hk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-HK"},{"@type":"Organization","@id":"https:\/\/amdl.com.hk\/#organization","name":"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong","url":"https:\/\/amdl.com.hk\/","logo":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/amdl.com.hk\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/amdl.com.hk\/wp-content\/uploads\/2022\/05\/AMDL-Logo_RGB_For-Online-use-01.png?fit=2584%2C709&ssl=1","contentUrl":"https:\/\/i0.wp.com\/amdl.com.hk\/wp-content\/uploads\/2022\/05\/AMDL-Logo_RGB_For-Online-use-01.png?fit=2584%2C709&ssl=1","width":2584,"height":709,"caption":"Asia Molecular Diagnostics Laboratory Limited (AMDL) \u4e9e\u6d32\u5206\u5b50\u8a3a\u65b7\u5be6\u9a57\u5ba4\u6709\u9650\u516c\u53f8 | \u9999\u6e2f Hong Kong"},"image":{"@id":"https:\/\/amdl.com.hk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/hk.linkedin.com\/company\/asia-molecular-diagnostics-laboratory"]},{"@type":"Person","@id":"https:\/\/amdl.com.hk\/#\/schema\/person\/7dcadaf75d73ac6327b3700429c56113","name":"amdlint","image":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/secure.gravatar.com\/avatar\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96fad0ebb13cb2081caae344b24263782c7525b1f463145ad5350500f3385a92?s=96&d=identicon&r=g","caption":"amdlint"},"url":"https:\/\/amdl.com.hk\/zh\/author\/amdlint\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pdypsj-2dN","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/posts\/8543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/users\/214404991"}],"replies":[{"embeddable":true,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/comments?post=8543"}],"version-history":[{"count":8,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/posts\/8543\/revisions"}],"predecessor-version":[{"id":8551,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/posts\/8543\/revisions\/8551"}],"wp:attachment":[{"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/media?parent=8543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/categories?post=8543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amdl.com.hk\/zh\/wp-json\/wp\/v2\/tags?post=8543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}